The independent source for health policy research, polling, and news.
181-200 of 342 results
Mental health courts have been touted as a means to help reduce the flow of people with mental illness into jails and prisons. But the specialized diversion programs can struggle to live up to that promise, and some say they’re a bad investment.
Thousands of medical devices are sold, and even implanted, with no safety tests.
Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.
For the patient, it was a quick and inexpensive virtual appointment. Why it cost 10 times what she expected became a mystery.
Thousands of people shared their experiences and related to the financial drain on families portrayed in the “Dying Broke” series, a joint project by KFF Health News and The New York Times that examined the costs of long-term care.
Lina Khan, chair of the FTC, says a recent lawsuit is meant to chill the consolidation of medical groups that results in higher prices for consumers. But it may be too late to curb price hikes.
The Biden administration wants to crack down on deceptive or misleading Medicare Advantage and drug plan sales tactics. It’s counting on beneficiaries to help catch offenders.
This illustrated report has been adapted from a KFF Health News article, “Many Autoimmune Disease Patients Struggle With Diagnosis, Costs, Inattentive Care” by Andy Miller, with artwork by Oona Tempest.
Convenient as it may be, beware of getting your blood drawn at a hospital. The cost could be much higher than at an independent lab, and your insurance might not cover it all.
The financial and emotional toll of providing and paying for long-term care is wreaking havoc on the lives of millions of Americans. Read about how a few families are navigating the challenges, in their own words.
Providers and health care advocates warn a proposed rule change in Montana would jeopardize immunity levels in child care centers and communities. Efforts to change vaccination exemption rules are underway in other states, too.
The number of men in the state taking paid family leave to bond with a new child has risen nearly 20% since the start of the pandemic.
Safe storage maps show gun owners where to put their firearms for safekeeping if they experience a mental health crisis. The idea has support among some gun enthusiasts, but legal obstacles threaten wider adoption.
A new, rapid genetic test shows promise in increasing diagnoses and improving treatment for some children with rare genetic conditions. Many insurers won’t cover it, but Florida's Medicaid program is among those that see benefits — and, potentially, savings.
A rise in cases of Vibrio vulnificus and its spread northward have heightened concern about the bacterium, which can cause human tissue to rot and skin to decay. The Centers for Disease Control and Prevention is trying to make more doctors aware of the dangerous pathogen.
The American College of Emergency Physicians will vote in early October on whether to disavow its 2009 research paper on excited delirium, which has been cited as a cause of death and used as a legal defense by police officers in several high-profile cases.
Parents, educators, and elected officials agree that investing in school-based prevention efforts could help curb the rising rate of youth drug overdoses. The well-known D.A.R.E. program is one likely choice, but its effectiveness is in question.
Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices in America have not delivered on those savings.
Mental health is being talked about more openly than ever, but the word “suicide” has remained largely taboo when describing how someone died. See why that’s slowly changing, what it means for people who grieve those deaths, and how candor can help prevent additional suicides.
In early 2020, U.S. public health labs received covid-19 tests from the Centers for Disease Control and Prevention that were flawed, as a result of poor design and contamination. Now the CDC is overhauling its lab operations, but efforts to be better prepared for future threats won’t be easy, observers say.
© 2026 KFF